Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
2008 Standout
Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis.
1984
Multicenter Palmaz stent renal artery stenosis revascularization registry report: Four‐year follow‐up of 1,058 successful patients
2002
Acromegaly
2006 Standout
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
2009 Standout
Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial
1999
Pheochromocytomas: Detection with11C Hydroxyephedrine PET
2004
Metabolic and cardiovascular profile in patients with Addison’s disease under conventional glucocorticoid replacement
2009
Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials
2003
Diabetic cardiovascular autonomic neuropathy: Prognosis, diagnosis and treatment
1994
The impact of atherosclerotic renovascular disease on diabetic renal failure
2002
Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma?
2003
Sensitivity and positive predictive value of CT, MRI and 123I-MIBG scintigraphy in localizing pheochromocytomas: A prospective study
2006
Neutrophils at work
2014 Standout
Treatment of Ostial Renal-Artery Stenoses with Vascular Endoprostheses after Unsuccessful Balloon Angioplasty
1997
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
1997 Standout
Drug addiction as a physical disease: The role of physical dependence and other chronic drug-induced neurophysiological changes in compulsive drug self-administration.
1998
Renal Artery Angioplasty: Technical Results and Clinical Outcome in 320 Patients
1995
Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
1988 Standout
Renal-Artery Stenosis
2001 Standout
Cushing's syndrome
2015 Standout
Phaeochromocytoma
2005 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Physiology and immunology of the cholinergic antiinflammatory pathway
2007 Standout
Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia
2005
SOCS2 negatively regulates growth hormone action in vitro and in vivo
2005
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Stents in the Treatment of Renal Artery Stenosis: Long-term Follow-up
1999
Advanced renovascular hypertension and renal insufficiency: Trends in medical comorbidity and surgical approach from 1970 to 1993
1995
X-ray analyses of aspartic proteinases
1990
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Treatment of renovascular hypertension: One year results of renal angioplasty
1995
Revascularization in atherosclerotic renal artery disease
1998
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
2016 Standout
Autonomic Vagal Nerve Dysfunction in Patients with Ulcerative Colitis
1993
Fibromuscular Dysplasia
2004 Standout
Peripheral and autonomic nerve function in 259 diabetic patients with peripheral neuropathy treated with ponalrestat (an aldose reductase inhibitor) or placebo for 18 months
1992
Addiction Motivation Reformulated: An Affective Processing Model of Negative Reinforcement.
2004 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Primary Stenting of Atherosclerotic Renal Artery Ostial Stenosis
1998
HORMONES AND HYPERTENSION
1989
Daily Interruption of Sedative Infusions in Critically Ill Patients Undergoing Mechanical Ventilation
2000 Standout
Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials
2003
Reflex control of immunity
2009 Standout
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
Follow-up of primary Palmaz-Schatz stent placement for atherosclerotic renal artery stenosis
1995
Primary renal artery stenting: Characteristics and outcomes after 363 procedures
2001
Excretion and ecotoxicity of pharmaceutical and personal care products in the environment
2005
Renal Artery Stent Placement: Utility in Lesions Difficult to Treat With Balloon Angioplasty
1997
Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers
2013
Long-Term Complications of Diabetes Mellitus
1993 Standout
Glucose metabolism and visceral fat in GH deficient adults: 1 year of GH replacement
2003
Sedation for the critically ill neurologic patient
1995
Effects of a Growth Hormone-Releasing Hormone Analog on Endogenous GH Pulsatility and Insulin Sensitivity in Healthy Men
2010
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Glucose Metabolism and Visceral Fat in GH Deficient Adults: Two Years of GH-Replacement
2004
Intervention for renal artery stenosis: endovascular and surgical roles
2005
Transcatheter Interventions for the Treatment of Peripheral Atherosclerotic Lesions: Part I
2001
Current Approaches and Recommended Algorithm for the Diagnostic Localization of Pheochromocytoma
2004
Outcome and Cost Comparison of Percutaneous Transluminal Renal Angioplasty, Renal Arterial Stent Placement, and Renal Arterial Bypass Grafting
1999
Sympathetic neural mechanisms in obstructive sleep apnea.
1995 Standout
A review on the occurrence of micropollutants in the aquatic environment and their fate and removal during wastewater treatment
2014 Standout
Effects of Growth Hormone and Its Secretagogues on Bone
2001
123I‐metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra‐adrenal phaeochromocytomas: CT and MRI correlation
2008
Ghrelin: Structure and Function
2005 Standout
Glucose Homeostasis and Safety in Patients with Acromegaly Converted from Long-Acting Octreotide to Pegvisomant
2005
Radiomics: Extracting more information from medical images using advanced feature analysis
2012 Standout
Physiology, Signaling, and Pharmacology of Galanin Peptides and Receptors: Three Decades of Emerging Diversity
2014
Imaging and cancer: A review
2008
Tensor Regression with Applications in Neuroimaging Data Analysis
2013 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence.
1994
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
The Impact of Glucocorticoid Replacement Regimens on Metabolic Outcome and Comorbidity in Hypopituitary Patients
2006
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
The Aldosterone???Renin Ratio in Screening for Primary Aldosteronism
2004
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Plasma noradrenaline correlates to sympathetic muscle nerve activity in normotensive man
1981
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Peptidomimetics—Tailored Enzyme Inhibitors
1994
Blood Pressure Outcome of Angioplasty in Atherosclerotic Renal Artery Stenosis
1998
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
2010 Standout
Diagnosis of Pheochromocytoma
1988
Molecular and Biotechnological Aspects of Microbial Proteases
1998 Standout
Management of growth hormone deficiency in adults
2007
Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover.
1988
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Sexual dimorphism of the somatotrophic axis
1998
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Human growth hormone receptor (GHR) expression in obesity: I. GHR mRNA expression in omental and subcutaneous adipose tissues of obese women
2011
Guanfacine
1986
A Field Guide to Foldamers
2001 Standout
Drug Effects on Aldosterone/Plasma Renin Activity Ratio in Primary Aldosteronism
2002
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
Drug addiction as a physical disease: The role of physical dependence and other chronic drug-induced neurophysiological changes in compulsive drug self-administration.
1998
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Autonomic nerve antibodies and autonomic nerve function in Type 1 and Type 2 diabetic patients
1991
Sympathetic Nervous Activity and Renal and Systemic Hemodynamics in Cirrhosis: Plasma Norepinephrine Concentration, Hepatic Extraction, and Renal Release
1982
A Current Review of the Etiology, Diagnosis, and Treatment of Pediatric Pheochromocytoma and Paraganglioma
2010
SOCS2 negatively regulates growth hormone action in vitro and in vivo
2005
Direct Renin Inhibitors as a New Therapy for Hypertension
2010
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Diabetic Autonomic Neuropathy
2003 Standout
Protein Glycoengineering Enabled by the Versatile Synthesis of Aminooxy Glycans and the Genetically Encoded Aldehyde Tag
2011 StandoutNobel
Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.
1990 Standout
Renal artery stenosis presenting as crescendo angina pectoris
1995
Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts
1982 Standout
Four-Year Follow-up of Palmaz-Schatz Stent Revascularization as Treatment for Atherosclerotic Renal Artery Stenosis
1998
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure
1982
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Diminished Polymorphonuclear Leukocyte Adherence
1980
Works of Per Manhem being referenced
Growth Hormone Replacement Therapy Induces Insulin Resistance by Activating the Glucose-Fatty Acid Cycle
2003
Effects of morning cortisol replacement on glucose and lipid metabolism in GH-treated subjects
2004
Impaired responses of plasma catecholamines to exercise in diabetic patients with abnormal heart rate reactions to tilt
1989
Inhibition of the Rise in FFA by Acipimox Partially Prevents GH-Induced Insulin Resistance in GH-Deficient Adults
2001
Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: A prospective randomized study
1993
The activity of the renin-angiotensin-aldosterone system before and during submaximal bicycle exercise in relation to circulatory catecholamines in patients with Type 1 (insulin-dependent) diabetes mellitus
1990
Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice. Primary and secondary evaluation for localization of phaeochromocytomas
2001
Plasma neuropeptide Y (NPY) and galanin before and during exercise in type 1 diabetic patients with autonomic dysfunction
1992
Prolonged Clonidine Treatment: Catecholamines, Renin Activity and Aldosterone Following Exercise in Hypertensives
1981
Effect of 6 months of GH treatment on myosin heavy chain composition in GH-deficient patients
1999
Effects of penbutolol and metoprolol on blood pressure, plasma catecholamines and renin activity in hypertensive patients
1983
Plasma catecholamine levels in the coronary sinus, the left renal vein and peripheral vessels in healthy males at rest and during exercise
1978
The Renin—Angiotensin Converting Enzyme Cascade: Renin and blood pressure
1984
Responses of Plasma Catecholamines to Tilt in Patients with Diabetes Mellitus
1984
Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice. Primary and secondary evaluation for localization of phaeochromocytomas
2001
Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: A prospective randomized study
1993
Blood pressure, heart rate, catecholamines and plasma renin activity following institution and withdrawal of guanfacine treatment in moderate hypertension.
1980
PLASMA NORADRENALINE AND BLOOD PRESSURE IN HYPOTHYROID PATIENTS: EFFECT OF GRADUAL THYROXINE TREATMENT
1984
A Study of the Renin Inhibitor H142 in Man
1985
Reduced bone mineral density in adults with growth hormone (GH) deficiency: increased bone turnover during 12 months of GH substitution therapy
1995
Plasma clonidine in relation to blood pressure, catecholamines, and renin activity during long-term treatment of hypertension
1982
The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender.
1996
Alcohol Withdrawal: Effects of Clonidine Treatment on Sympathetic Activity, the Renin‐Aldosterone System, and Clinical Symptoms
1985